Keyphrases
Hormonal Contraception
100%
Cancer Risk
100%
Oral Contraceptives
100%
Duration of Use
66%
Protective Effect
66%
Combined Oral Contraceptives
66%
Oral Contraceptive Use
66%
Embase
33%
Prospective Cohort Study
33%
Overall Risk
33%
Risk Reduction
33%
High Risk
33%
Current Users
33%
Endometrial Cancer
33%
BRCA mutation Carriers
33%
Prolonged Follow-up
33%
Contraceptive Methods
33%
Liver Cancer
33%
PubMed
33%
Cervical Cancer
33%
Cancer Mortality
33%
Excess Risk
33%
Relative Risk
33%
Mutation Carriers
33%
Long-term Benefit
33%
BRCA2
33%
Low Compliance
33%
Chemoprevention
33%
Young Women
33%
Breast Cancer Risk
33%
Cancer Incidence
33%
Significant Risk Factors
33%
Ovarian Cancer Risk
33%
Breast Cancer Susceptibility Gene 1 (BRCA1)
33%
Medicine and Dentistry
Oral Contraceptive Agent
100%
Oral Contraceptive
100%
Hormonal Contraception
100%
Malignant Neoplasm
100%
Cancer Risk
66%
Oral Contraceptive Use
66%
Cancer Mortality
33%
Cervical Cancer
33%
Case-Control Study
33%
Prospective Cohort Study
33%
Uterine Cancer
33%
Cancer Incidence
33%
BRCA Mutation
33%
Ovarian Cancer
33%
Chemoprophylaxis
33%
Liver Cancer
33%
Risk Reduction
33%
Breast Cancer
33%
Pharmacology, Toxicology and Pharmaceutical Science
Oral Contraceptive
100%
Malignant Neoplasm
100%
Oral Contraceptive Agent
75%
Cancer Mortality
25%
Liver Cancer
25%
Case-Control Study
25%
Ovary Cancer
25%
Prospective Cohort Study
25%
Liver Tumor
25%
Cancer Incidence
25%
Breast Cancer
25%
Uterine Cervix Cancer
25%
Endometrium Cancer
25%